![Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19 | EMBO Molecular Medicine Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19 | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/f5cea1c8-c904-421b-9545-a91ffc444e00/emmm202114150-fig-0001-m.jpg)
Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19 | EMBO Molecular Medicine
![Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19 | EMBO Molecular Medicine Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19 | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/8b98784c-8379-472b-b91d-1baeb1f3e264/emmm202114150-fig-0007-m.jpg)
Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19 | EMBO Molecular Medicine
![Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths | Science Immunology Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.abl4340/asset/086b96de-b645-44cf-ac5f-ca5886c76707/assets/images/large/sciimmunol.abl4340-f2.jpg)
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths | Science Immunology
![Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19 | EMBO Molecular Medicine Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19 | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/07f72abe-a7d2-4ba2-a913-0d71c1260e66/emmm202114150-abs-0001-m.jpg)
Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19 | EMBO Molecular Medicine
![Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths | Science Immunology Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths | Science Immunology](https://www.science.org/cms/asset/0ff72c75-9fef-4ab6-a3cf-faa9d06c12a7/keyimage.gif)
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths | Science Immunology
![BREE Kadın Toulouse 1 askılı çanta, 4 x 20 x 19 cm Mavi Size: 4x20x19 cm (B x H x T) : Amazon.com.tr: Moda BREE Kadın Toulouse 1 askılı çanta, 4 x 20 x 19 cm Mavi Size: 4x20x19 cm (B x H x T) : Amazon.com.tr: Moda](https://m.media-amazon.com/images/I/31Ub08xAfJL._AC_SY780_.jpg)
BREE Kadın Toulouse 1 askılı çanta, 4 x 20 x 19 cm Mavi Size: 4x20x19 cm (B x H x T) : Amazon.com.tr: Moda
![Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths | Science Immunology Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.abl4340/asset/db918b29-eab9-46c0-b0ac-02f1ffcdc327/assets/images/large/sciimmunol.abl4340-f6.jpg)
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths | Science Immunology
![Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths | Science Immunology Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.abl4340/asset/9b4d593f-60af-4a17-aafa-5ab9cbfae006/assets/images/large/sciimmunol.abl4340-f1.jpg)